TR200904341A2 - Rosuvastatin kalsiyum içeren kararlı farmasötik bileşimler. - Google Patents

Rosuvastatin kalsiyum içeren kararlı farmasötik bileşimler.

Info

Publication number
TR200904341A2
TR200904341A2 TR2009/04341A TR200904341A TR200904341A2 TR 200904341 A2 TR200904341 A2 TR 200904341A2 TR 2009/04341 A TR2009/04341 A TR 2009/04341A TR 200904341 A TR200904341 A TR 200904341A TR 200904341 A2 TR200904341 A2 TR 200904341A2
Authority
TR
Turkey
Prior art keywords
pharmaceutical compositions
rosuvastatin calcium
compositions containing
stable pharmaceutical
containing rosuvastatin
Prior art date
Application number
TR2009/04341A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2009/04341A priority Critical patent/TR200904341A2/tr
Priority to PCT/TR2010/000103 priority patent/WO2010140992A1/en
Publication of TR200904341A2 publication Critical patent/TR200904341A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş, en az % 60 oranında laktoz içermek suretiyle kararlı hale gelen, oral rosuvastatin kalsiyum fannasötik bileşimine, bu bileşimin hazırlanması için yöntemlere ve hazırlanan bileşimin tedavi amaçlı kullanımına dairdir.
TR2009/04341A 2009-06-03 2009-06-03 Rosuvastatin kalsiyum içeren kararlı farmasötik bileşimler. TR200904341A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2009/04341A TR200904341A2 (tr) 2009-06-03 2009-06-03 Rosuvastatin kalsiyum içeren kararlı farmasötik bileşimler.
PCT/TR2010/000103 WO2010140992A1 (en) 2009-06-03 2010-05-27 Stable pharmaceutical compositions containing rosuvastatin calcium

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2009/04341A TR200904341A2 (tr) 2009-06-03 2009-06-03 Rosuvastatin kalsiyum içeren kararlı farmasötik bileşimler.

Publications (1)

Publication Number Publication Date
TR200904341A2 true TR200904341A2 (tr) 2010-12-21

Family

ID=43020424

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2009/04341A TR200904341A2 (tr) 2009-06-03 2009-06-03 Rosuvastatin kalsiyum içeren kararlı farmasötik bileşimler.

Country Status (2)

Country Link
TR (1) TR200904341A2 (tr)
WO (1) WO2010140992A1 (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101302306B1 (ko) 2011-01-26 2013-09-03 씨제이제일제당 (주) 고지혈증 복합제
CN104434826B (zh) * 2014-11-08 2018-03-20 鲁南贝特制药有限公司 一种瑞舒伐他汀钙分散片
KR20220026641A (ko) * 2020-08-25 2022-03-07 주식회사 대웅제약 고혈압 및 고지혈증을 치료 또는 예방하기 위한 단일 제형의 약학 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2648897B2 (ja) 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
HU9203780D0 (en) 1991-12-12 1993-03-29 Sandoz Ag Stabilized pharmaceutical products of hmg-coa reductase inhibitor and method for producing them
GB0001621D0 (en) 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
HU227610B1 (en) 2006-09-18 2011-09-28 Richter Gedeon Nyrt Pharmaceutical compositions containing rosuvastatin potassium
WO2008062476A2 (en) * 2006-10-31 2008-05-29 Glenmark Pharmaceutical Limited Pharmaceutical composition comprising rosuvastatin or pharmaceutically accepatble salts thereof
WO2008075320A2 (en) * 2006-12-21 2008-06-26 Ranbaxy Laboratories Limited Antilipidemic pharmaceutical compositions and process for preparation thereof
GB0713707D0 (en) * 2007-07-13 2007-08-22 Generics Uk Ltd Stable compositions
CA2637977A1 (en) * 2008-07-15 2010-01-15 Pharmascience Inc. Dosage form containing a statin
PL386051A1 (pl) * 2008-09-09 2010-03-15 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Stabilna doustna kompozycja farmaceutyczna zawierająca farmaceutycznie dopuszczalną sól kwsu [(E)-7-[4-(4-fluorofenylo)-6-izopropylo-2-[metylo(metylosulfonylo)amino]pirymidyn-5-ylo] (3R,5S)-3,5-dihydroksyhept-6-enowego
TR200902077A2 (tr) * 2009-03-17 2010-01-21 Sanovel İlaç San.Veti̇c.A.Ş. Stabil rosuvastatin kompozisyonları

Also Published As

Publication number Publication date
WO2010140992A1 (en) 2010-12-09

Similar Documents

Publication Publication Date Title
MX377553B (es) Composicion farmaceutica estable y metodos de uso de la misma.
MX348823B (es) Formulaciones estables de linaclotida.
EA200970581A1 (ru) Кристаллическое твёрдое основание разагилина
UA103915C2 (ru) Твердая лекарственная форма, которая содержит линаглиптин и ингибитор sglt2, и ее применение
GEP20146146B (en) Pyrrolopyrimidine compounds as inhibitors of cdk4/6
EA201001680A1 (ru) Соединения бензолсульфонамидтиазола и оксазола
EA200971115A1 (ru) Новые ингибиторы обратной транскриптазы вич
MX2009010977A (es) Metodos de administracion de tetrahidrobiopterina, composiciones asociadas y metodos de medicion.
GEP20135744B (en) Quinuclidine carbonate derivatives and medicinal compositions containing the same
EA201200794A1 (ru) Триазолопиридины
MX2019012939A (es) Formulaciones que contienen linaclotida para administracion oral.
EA201001639A1 (ru) Композиции и способы их получения и применения
MX2011011486A (es) Composiciones orales que contienen compuestos de poliguandino y metodos de preparacion y uso de las mismas.
UA109661C2 (uk) Фармацевтична композиція співкристалів трамадолу і коксибів
EA201190017A1 (ru) Аминоэфирные производные алкалоидов и их медицинские композиции
GB2511685A (en) Muscarinic m1 receptor agonists
EP2528578A4 (en) DENTAL COMPOSITION USING A CALCIUM SOURCE
UA112055C2 (uk) Солі 4-[2-[[5-метил-1-(2-нафталініл)-1h-піразол-3-іл]оксі]етил]морфоліну
MA32776B1 (fr) Inhibiteurs de l'akt et de la p70 s6 kinase
EA201300034A1 (ru) Фармацевтические композиции, содержащие иматиниб или его фармацевтически приемлемую соль, и способы их получения
TW200621313A (en) Pharmaceutical compositions
EA201590364A1 (ru) Применение орвепитанта, его солей и кристаллических форм и композиций, его содержащих, для лечения зуда
EA201000434A1 (ru) Сокристаллы пириметанила и дитианона
UA103329C2 (ru) Соли соединений-ингибиторов вич
MA32479B1 (fr) Compoés nouveaux actifs comme antagonistes des recepteurs muscariniques